litlas
ログインアカウント作成

Marc Peeters

1985–2025 年に発表

208
論文数
35,263
被引用数
99
h 指数
201
i10 指数

被引用数

Marc Peeters の年別被引用数1987 年: 被引用 2 件1990 年: 被引用 4 件1991 年: 被引用 9 件1992 年: 被引用 6 件1993 年: 被引用 3 件1994 年: 被引用 5 件1995 年: 被引用 13 件1996 年: 被引用 18 件1997 年: 被引用 19 件1998 年: 被引用 24 件1999 年: 被引用 45 件2000 年: 被引用 63 件2001 年: 被引用 84 件2002 年: 被引用 113 件2003 年: 被引用 115 件2004 年: 被引用 137 件2005 年: 被引用 129 件2006 年: 被引用 142 件2007 年: 被引用 144 件2008 年: 被引用 187 件2009 年: 被引用 311 件2010 年: 被引用 311 件2011 年: 被引用 294 件2012 年: 被引用 264 件2013 年: 被引用 283 件2014 年: 被引用 337 件2015 年: 被引用 305 件2016 年: 被引用 265 件2017 年: 被引用 276 件2018 年: 被引用 233 件2019 年: 被引用 854 件2020 年: 被引用 829 件2021 年: 被引用 851 件2022 年: 被引用 703 件2023 年: 被引用 537 件2024 年: 被引用 973 件2025 年: 被引用 461 件2026 年: 被引用 16 件1988〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,631 件、この内訳の 21%中国: 引用元論文 1,069 件、この内訳の 8.5%イタリア: 引用元論文 923 件、この内訳の 7.4%イギリス: 引用元論文 802 件、この内訳の 6.4%ドイツ: 引用元論文 776 件、この内訳の 6.2%フランス: 引用元論文 623 件、この内訳の 5%ベルギー: 引用元論文 512 件、この内訳の 4.1%スペイン: 引用元論文 512 件、この内訳の 4.1%オランダ: 引用元論文 479 件、この内訳の 3.8%日本: 引用元論文 403 件、この内訳の 3.2%カナダ: 引用元論文 396 件、この内訳の 3.1%オーストラリア: 引用元論文 340 件、この内訳の 2.7%
0%21%その他 24.5%

機関

分野

  • Medicine56.8%
  • Biochemistry, Genetics and Molecular Biology26.7%
  • Immunology and Microbiology6.1%
  • Engineering4.7%
  • Neuroscience0.7%
  • Nursing0.6%
  • その他4.4%

トピック

  • Colorectal Cancer Treatments and Studies7.4%
  • Inflammatory Bowel Disease3.7%
  • Cancer Genomics and Diagnostics3.6%
  • Genetic factors in colorectal cancer2.4%
  • Lung Cancer Treatments and Mutations2.3%
  • Colorectal Cancer Surgical Treatments2.1%
  • その他78.5%

共著者

全論文

検索で開く
  1. Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    著者: Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio García‐Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Éveline Boucher, Marc Peeters, Ben Tran, Heinz‐Josef Lenz, Alberto Zaniboni, Howard S. Höchster, James M. Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu - New England Journal of Medicine 2015 被引用: 1,431

  2. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

    著者: John H. Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, Elena Élez, David L. Bajor, Chiara Cremolini, Federico Sanchez, Michael Stecher, Wentao Feng, Tanios Bekaii‐Saab, Eric Van Cutsem, Marc Peeters, Marc Van den Evnde, Thierry André, Christophe Borg, Matthieu Sarabi, François Ghiringhelli, Benoist Chibaudel, Salvatore Siena, Chiara Cremolini, Maria Giulia Zampino, Elena Élez, Susana R. Keranen, Ramón Salazar, Pilar Alfonso, John H. Strickler, Andrea Cercek, Kimmie Ng, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, David L. Bajor, Tanios Bekaii‐Saab, Olumide B. Gbolahan, Patrick M. Boland, Daniel Berg, Federico Sanchez, Timothy F. Goggins, Federico Sanchez, Howard A. Burris, Johanna C. Bendell, Darryl Outlaw, Isaac Tafur, Ardaman Shergill, Daniel V.T. Catenacci, Jun Gong, Ignacio Garrido‐Laguna, Gene Grant Finley, Benjamin A. Weinberg, Anthony F. Shields, Philip Philip, Anita Turk, Anthony Nguyen, Fadi Braiteh, Vijay Patel, William Harwin, Ian Anderson, Ajay Kundra, Christopher S. Chen, James M. Ford, Madappa N. Kundranda, Danny Nguyen, Suresh Ratnam, Donald Richards, Sujatha Nallapareddy, Sridhar Beeram, Scott McKenney, Spencer H. Shao, Scott McKenney, Spencer H. Shao - The Lancet Oncology 2023 被引用: 245

  3. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

    著者: Dirk Arnold, B. Lueza, Jean-Yves Douillard, Marc Peeters, Heinz‐Josef Lenz, Alan P. Venook, Volker Heinemann, Eric Van Cutsem, Jean‐Pierre Pignon, Josep Tabernero, Andrés Cervantes, Fortunato Ciardiello - Annals of Oncology 2017 被引用: 836

  4. Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.

    著者: Kanwal Raghav, Salvatore Siena, Atsuo Takashima, Takeshi Kato, Marc Van den Eynde, Maria Di Bartolomeo, Yoshito Komatsu, Hisato Kawakami, Marc Peeters, Thierry André, Sara Lonardi, Kensei Yamaguchi, Jeanne Tie, Cristina Grávalos Castro, John H. Strickler, Daniel Barrios, Qi Yan, Takahiro Kamio, Kojiro Kobayashi, Takayuki Yoshino - Journal of Clinical Oncology 2023 被引用: 77

  5. Cellular senescence in cancer: clinical detection and prognostic implications

    著者: Andreas Domen, Christophe Deben, Jasper Verswyvel, Tal Flieswasser, Hans Prenen, Marc Peeters, Filip Lardon, An Wouters - Journal of Experimental & Clinical Cancer Research 2022 被引用: 91

  6. Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

    著者: Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, David Chang - Journal of Clinical Oncology 2008 被引用: 3,152

  7. Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

    著者: Kanwal Raghav, Salvatore Siena, Atsuo Takashima, Takeshi Kato, Marc Van den Eynde, Filippo Pietrantonio, Yoshito Komatsu, Hisato Kawakami, Marc Peeters, Thierry André, Sara Lonardi, Kensei Yamaguchi, Jeanne Tie, Cristina Grávalos Castro, Hung‐Chih Hsu, John H. Strickler, Tae‐You Kim, Yongjun Cha, Daniel Barrios, Qi Yan, Takahiro Kamio, Kojiro Kobayashi, Aislyn Boran, Makito Koga, John Allard, Takayuki Yoshino - The Lancet Oncology 2024 被引用: 126

  8. Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives

    著者: Joe Ibrahim, Marc Peeters, Guy Van Camp, Ken Op de Beeck - European Journal of Cancer 2022 被引用: 103

  9. Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

    著者: Eric Van Cutsem, Marc Peeters, Salvatore Siena, Yves Humblet, Alain Hendlisz, Bart Neyns, Jean-Luc Canon, Jean–Luc Van Laethem, Joan Maurel, Gary Richardson, Michael Wolf, Rafael G. Amado - Journal of Clinical Oncology 2007 被引用: 1,998

  10. A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy

    著者: Jorrit De Waele, Tias Verhezen, Sanne van der Heijden, Zwi Berneman, Marc Peeters, Filip Lardon, An Wouters, Evelien Smits - Journal of Experimental & Clinical Cancer Research 2021 被引用: 109

  11. Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review

    著者: Ruben Van den Brande, Erwin M. J. Cornips, Marc Peeters, Piet Ost, Charlotte Billiet, Erik Van de Kelft - Journal of bone oncology 2022 被引用: 190

  12. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    著者: Marianne Pavel, John D. Hainsworth, Éric Baudin, Marc Peeters, Dieter Hörsch, Robert Winkler, Judith Klimovsky, David Lebwohl, Valentine Jehl, Edward M. Wolin, Kjell Öberg, Eric Van Cutsem, James C. Yao - The Lancet 2011 被引用: 1,052

  13. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

    著者: Timothy Price, Marc Peeters, Tae Won Kim, Jin Li, Stefano Cascinu, Paul Ruff, Atilli Satya Suresh, Anne Thomas, Sergei Tjulandin, Kathy Zhang, Swaminathan Murugappan, Roger Sidhu - The Lancet Oncology 2014 被引用: 470

  14. Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects

    著者: Jinthe Van Loenhout, Marc Peeters, Annemie Bogaerts, Evelien Smits, Christophe Deben - Antioxidants 2020 被引用: 97

  15. Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer

    著者: Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Jorrit De Waele, Christophe Hermans, Hilde Lambrechts, Bart Cuypers, Kris Laukens, Esther Bartholomeus, Vasiliki Siozopoulou, Winnok H. De Vos, Marc Peeters, Evelien Smits, Christophe Deben - Redox Biology 2021 被引用: 109

  16. Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma

    著者: Jinthe Van Loenhout, Laurie Freire Boullosa, Delphine Quatannens, Jorrit De Waele, Céline Merlin, Hilde Lambrechts, Ho Wa Lau, Christophe Hermans, Abraham Lin, Filip Lardon, Marc Peeters, Annemie Bogaerts, Evelien Smits, Christophe Deben - Cells 2021 被引用: 72

  17. Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors

    著者: Antoine Hollebecque, Hyun C. Chung, Maria J. de Miguel, Antoine Italiano, Jean-Pascal Machiels, Chia-Chi Lin, Neesha C. Dhani, Marc Peeters, Victor Moreno, Wu-Chou Su, Kay Hoong Chow, Violeta R. Galvao, Michelle Carlsen, Danni Yu, Anna M. Szpurka, Yumin Zhao, Shelly L. Schmidt, Leena Gandhi, Xiaojian Xu, Yung-Jue Bang - Clinical Cancer Research 2021 被引用: 62

  18. A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

    著者: Gerald S. Falchook, Marc Peeters, Sylvie Rottey, Luc Dirix, Radka Obermannová, Jonathan Cohen, Ruth Perets, Ronnie Shapira Frommer, Todd M. Bauer, Judy S. Wang, Richard D. Carvajal, Joshua K. Sabari, Sonya C. Chapman, Wei Zhang, Boris Calderón, Daniel A. Peterson - Investigational New Drugs 2021 被引用: 58

  19. Probiotics enhance the clearance of human papillomavirus-related cervical lesions

    著者: Véronique Verhoeven, Nathalie Renard, Amin Makar, Paul Van Royen, John-Paul Bogers, Filip Lardon, Marc Peeters, Marc Baay - European Journal of Cancer Prevention 2012 被引用: 133

  20. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

    著者: Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, Jorrit De Waele, Jonas R.M. Van Audenaerde, Elly Marcq, Julie Jacobs, Abraham Lin, Eva Lion, Heleen Dewitte, Marc Peeters, Sylvia Dewilde, Filip Lardon, Annemie Bogaerts, Christophe Deben, Evelien Smits - Cancers 2019 被引用: 113

  21. Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors

    著者: Antoine Hollebecque, Hyun Cheol Chung, de Miguel, Maria J., Antoîne Italiano, Jean‐Pascal Machiels, Chia‐Chi Lin, Neesha C. Dhani, Marc Peeters, Víctor Moreno, Wu‐Chou Su, Kay Hoong Chow, Violeta Régnier Galvão, Michelle Carlsen, Danni Yu, Anna M. Szpurka, Yumin Zhao, Shelly Schmidt, Leena Gandhi, Xiaojian Xu, Yung‐Jue Bang - 2021 被引用: 43

  22. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

    著者: Charles S. Fuchs, Sérgio Jobim Azevedo, Takuji Okusaka, Jean‐Luc Van Laethem, Lara Lipton, Hanno Riess, Cezary Szczylik, Malcolm J. Moore, Marc Peeters, G. Bodoky, Masafumi Ikeda, Bohuslav Melichar, Radim Němeček, S. Ohkawa, Anna Świeboda-Sadlej, Sergei Tjulandin, Eric Van Cutsem, Robert D. Loberg, Vincent Haddad, Jennifer Gansert, Bruce Allen Bach, Alfredo Carrato - Annals of Oncology 2015 被引用: 164

  23. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer

    著者: Maxim Le Compte, Edgar Cardenas De La Hoz, Sofía Peeters, Felicia Rodrigues Fortes, Christophe Hermans, Andreas Domen, Evelien Smits, Filip Lardon, Timon Vandamme, Abraham Lin, Steve Vanlanduit, Geert Roeyen, Steven Van Laere, Hans Prenen, Marc Peeters, Christophe Deben - npj Precision Oncology 2023 被引用: 37

  24. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

    著者: P. Rutgeerts, Marc Peeters, Martin Hiele, G. Vantrappen, F Pennincx, Raymond Aerts, Raymond Kerremans, K Goboes - The Lancet 1991 被引用: 760